GPR146 Inhibitors

GPR146 inhibitors belong to a class of small molecules that specifically target and modulate the activity of the G protein-coupled receptor 146 (GPR146), a member of the GPCR family. GPR146, also known as chemokine-like receptor 1 (CMKLR1), is a cell surface receptor primarily expressed in immune cells and adipose tissues. It plays a crucial role in various physiological processes, particularly in the regulation of inflammation, immune responses, and metabolic functions. GPR146 is activated by its endogenous ligands, such as chemerin, and its activation triggers downstream signaling cascades that contribute to the regulation of cellular processes. GPR146 inhibitors are designed to bind selectively to the GPR146 receptor, modulating its activity in a way that can lead to alterations in intracellular signaling pathways and cellular responses. These inhibitors typically work by either blocking the binding of endogenous ligands to GPR146 or by interfering with downstream signaling events initiated by receptor activation. By targeting GPR146, these inhibitors have the potential to influence immune responses and metabolic processes, making them valuable tools for research into the role of GPR146 in various physiological contexts.